Brainstorm Cell Therapeutics Inc (BCLI)

May 10, 2025

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2024 Earnings Call Transcript - MSN

May 10, 2025

May 09, 2025

Stem Cell Therapy Market 2025: Technical Signs Point Higher Growth Levels - newstrail.com

May 09, 2025

May 08, 2025

SHAREHOLDER ALERT: Potential Recovery for Brainstorm Cell Therapeutics Inc. (BCLI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 08, 2025

May 07, 2025

BrainStorm Cell Therapeutics to Announce First Quarter Results and Provide a Corporate Update on May 15, 2025 - Stock Titan

May 07, 2025

May 06, 2025

BrainStorm's ALS Treatment Breakthrough: New Biomarker Data Shows Promise as FDA-Approved Trial Approaches - Stock Titan

May 06, 2025

May 05, 2025

StockNews.com Begins Coverage on Brainstorm Cell Therapeutics (NASDAQ:BCLI) - Defense World

May 05, 2025

May 05, 2025

Geode Capital Management LLC Sells 630,315 Shares of Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) - Defense World

May 05, 2025

May 01, 2025

5 Best Stem Cell Companies to Invest In (May 2025) - Securities.io

May 01, 2025

Apr 30, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 30, 2025

Apr 29, 2025

INVESTOR ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 2, 2024 in Brainstorm Cell LawsuitBCLI - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

BCLI’s Market Whiplash: -50.66% YTD Decline, -17.04% Plunge in 30 Days - investchronicle.com

Apr 29, 2025

Apr 29, 2025

BrainStorm's NurOwn® Data Selected as Breakthrough Science for Presentation at ISCT 2025 Meeting - marketscreener.com

Apr 29, 2025

Apr 27, 2025

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.com - Defense World

Apr 27, 2025

Apr 22, 2025

Stem Cell Therapy Market Size, Share & Trends Analysis 2025-2032 | Osiris Therapeutics, Inc., Kolon TissueGene - newstrail.com

Apr 22, 2025

Apr 21, 2025

Brainstorm Cell Therapeutics adjusts quorum requirement By Investing.com - Investing.com India

Apr 21, 2025

Apr 21, 2025

Brainstorm Cell Therapeutics adjusts quorum requirement - Investing.com

Apr 21, 2025

Apr 19, 2025

StockNews.com Initiates Coverage on Brainstorm Cell Therapeutics (NASDAQ:BCLI) - Defense World

Apr 19, 2025

Apr 19, 2025

Brainstorm Cell Therapeutics (NASDAQ:BCLI) Earns Hold Rating from Analysts at StockNews.com - American Banking and Market News

Apr 19, 2025

Apr 17, 2025

Brainstorm seeks FDA OK to launch NurOwn Phase 3b trial in ALS - ALS News Today

Apr 17, 2025

Apr 10, 2025

BrainStorm advances ALS therapy with FDA trial submission By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 10, 2025

Apr 10, 2025

BrainStorm advances ALS therapy with FDA trial submission - Investing.com

Apr 10, 2025

Apr 10, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Apr 10, 2025

Apr 10, 2025

BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn® in ALS - Nasdaq

Apr 10, 2025

Apr 09, 2025

Indo-Asian News Service - Indo-Asian News Service (IANS)

Apr 09, 2025

Apr 09, 2025

BrainStorm Cell Therapeutics (BCLI)Fundamentals Update 09042025 - Smartkarma

Apr 09, 2025

Apr 04, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 04, 2025

Apr 01, 2025

Stacy Lindborg, PhD's Profile Page - Technology Networks

Apr 01, 2025

Apr 01, 2025

BrainStorm Cell Therapeutics Reports 2024 Financial Results - TipRanks

Apr 01, 2025

Mar 31, 2025

BrainStorm Cell Therapeutics’ Earnings Call Highlights Progress and Challenges - TipRanks

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Brainstorm Cell Therapeutics Q4 2024 highlights cost-cutting - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

Earnings call transcript: Brainstorm Cell Therapeutics Q4 2024 highlights cost-cutting By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

Brainstorm Cell Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 31, 2025

Mar 31, 2025

SHAREHOLDER ALERT: Potential Recovery for Brainstorm Cell Therapeutics Inc. (BCLI) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Mar 31, 2025

Mar 31, 2025

BRAINSTORM CELL THERAPEUTICS INC. SEC 10-K Report - TradingView

Mar 31, 2025

Mar 31, 2025

SEC Form 10-K filed by Brainstorm Cell Therapeutics Inc. - Quantisnow

Mar 31, 2025

Mar 31, 2025

Brainstorm Cell Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits - Quantisnow

Mar 31, 2025

Mar 31, 2025

BrainStorm Cell Therapeutics Announces Full Year 2024 Financial Results and Provides Corporate Update - Nasdaq

Mar 31, 2025

Mar 29, 2025

INVESTOR ALERT: Potential Recovery for Brainstorm Cell Therapeutics Inc. (BCLI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Mar 29, 2025

Mar 29, 2025

Brainstorm Cell Therapeutics (BCLI) to Release Earnings on Monday - Defense World

Mar 29, 2025

Mar 28, 2025

Brainstorm Cell Therapeutics Inc expected to post a loss of 38 cents a shareEarnings Preview - TradingView

Mar 28, 2025

Mar 27, 2025

Brainstorm Cell Therapeutics gains extension from Nasdaq - Investing.com

Mar 27, 2025

Mar 27, 2025

Brainstorm Cell Therapeutics gains extension from Nasdaq By Investing.com - Investing.com India

Mar 27, 2025

Mar 26, 2025

BrainStorm Cell Therapeutics Granted Compliance Extension from N - GuruFocus.com

Mar 26, 2025

Mar 26, 2025

BrainStorm Cell Therapeutics Granted Compliance Extension from Nasdaq - MarketScreener

Mar 26, 2025

Mar 26, 2025

BrainStorm Wins Critical Nasdaq Extension: New ALS Study and Strategic Plans Unveiled - Stock Titan

Mar 26, 2025